VIRGO Consortium

Download Profile PDF
At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: Dutch Life Sciences Health Sector
  • Initiator Type: Government
  • Disease focus:
    Acute/Chronic Infectious Disease
  • Location: Europe

Abstract

The VIRGO Consortium focuses on providing the infrastructure for virus discovery and for advancing knowledge of viruses and the mechanisms of mutual virus-host interactions, which feed into the subsequent development of novel interventions, diagnostics, and prognostics at the levels of both individual patients and populations. It provides valuable leads for the development of novel antiviral drugs, vaccines, and other therapeutics; treatment regimens; and guidance as well as prevention strategies.

Mission

VIRGO aims at an improved understanding of major acute and chronic viral diseases, such as influenza, hepatitis, and acquired immunodeficiency syndrome (AIDS). These viral diseases constitute the majority of infectious diseases in the Netherlands and beyond. VIRGO studies the interaction between viruses causing these diseases and their hosts at a molecular level.

VIRGO aims to develop new approaches to interfere in the infection processes, for example, to prevent infection by designing new or improved vaccines, or improve clinical management of viral infections with novel diagnostic tools. To achieve these goals VIRGO unites the top research institutes in the field in the Netherlands.

Financing

VIRGO is a public-private partnership of seven academic institutions, three research organizations, and 10 private-sector companies that has received part of the sector-wide €81 million FES grant awarded to the Dutch Life Sciences and Health sector. In addition VIRGO is supported by NGI (Health Cluster) and the Dutch Ministry of Health. Together with NEUROBsik, VIRGO forms the DRUGS cluster.

Points of Contact

Wytemaweg 80, room Ee 17-51
3015 CN Rotterdam
The Netherlands
phone: +31 10 704 4770

Sponsors & Partners

AIMM Therapeutics

AMC – Medical Microbiology

Bristol-Myers Squibb (BMS)

Erasmus MC

F. Hoffman-La Roche Ltd.

Gilead Sciences

GlaxoSmithKline

Leiden University

LUMC – Infectious Diseases

Netherlands Proteomics Center

Novavax AB

Psynova Neurotech

Radboud  University Nijmegen Medical Center (RUNMC)

RIVM – Infectious Diseases

Thermo Scientific Dionex

UMC Utrecht

University of Groningen

Utrecht University

ViroClinics Biosciences

Vironovative

Last Updated: 04/08/2016
The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.
Register your consortium  
All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.